
0:00
13:29
This week's episode focuses on metastatic non-small cell lung cancer - the quickly growing and changing systemic therapy landscape, including traditional chemotherapy, immunotherapy, and targeted agents. Since our last recording the number of FDA-approved targeted drugs has significantly expanded.
Więcej odcinków z kanału "Two Onc Docs"



Nie przegap odcinka z kanału “Two Onc Docs”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








